Blake Insomnia Therapeutics Inc. announced the appointment of Dr. Eric Leire to join CEO Birger Jan Olsen on its Board of Directors. Dr. Leire has currently been the CEO of DanDrit Biotech which is developing a dendritic cell-based immunotherapy for the treatment of advanced colorectal cancer (Phase III clinical trials). He also serves on the Board of Novicol International Holding Inc.